CNE100001500
CNE100001500
JINCHENG PHARM
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 5.29B EUR | 4.76B EUR | 5.34B EUR | 5.37B EUR |
Enterprise Value | 4.66B EUR | 4.13B EUR | 4.9B EUR | 4.92B EUR |
Valuation Multiples | ||||
Trailing P/E | 36.26x | 31.42x | 67.82x | 95.91x |
Forward P/E | 7.49x | -- | -- | -- |
Price to Sales | 1.87x | 2.11x | 2.43x | 2.48x |
Price to Book | 1.4x | 1.27x | 1.43x | 1.47x |
EV/Revenue | 1.65x | 1.83x | 2.23x | 2.27x |
EV/EBITDA | 9.67x | 17.03x | 28.31x | 55.2x |
Price to FCF (P/FCF) | 25.4x | 18.22x | 20.28x | 30.21x |
EV/FCF | 22.39x | 15.82x | 18.61x | 27.7x |
FCF Yield | 3.94% | 5.49% | 4.93% | 3.31% |